Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019929192> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2019929192 endingPage "842" @default.
- W2019929192 startingPage "835" @default.
- W2019929192 abstract "Experimental evidence has demonstrated that monoclonal antibody (MAb) 13B8.2, a workshop-qualified anti-CD4 MAb, (1) inhibits in vitro syncytium formation as well as in vitro HIV infection of CD4+ T cells; (2) delivers negative signals to T cells, thus preventing T-cell activation and viral replication; (3) contributes to CD4+ T-cell clearance by its Fc portion, and (4) induces an immune response by the patient, contributing potentially to an anti-idiotypic response of interest for the control of the immune parameters of the disease. On this basis a phase I study combining zidovudine treatment and a 10-day course of anti-CD4 MAb was performed in seven AIDS patients (Centers for Disease Control group IV). The treatment was well tolerated. MAb dosage and schedule were adjusted on the basis of circulating CD4+ cells and MAb pharmacokinetics; immunological and virological parameters were also monitored. One patient presented a transient increment in CD4+ T cells associated with augmented T-cell function, the suppression of p24 in the serum and a negative RT assay. A second patient had a steady increment of CD4+ T cells after completion of the treatment, with a transient decrease of serum p24 5 days after completion of the anti-CD4 protocol." @default.
- W2019929192 created "2016-06-24" @default.
- W2019929192 creator A5000969643 @default.
- W2019929192 creator A5005540742 @default.
- W2019929192 creator A5010761183 @default.
- W2019929192 creator A5029679351 @default.
- W2019929192 creator A5032703463 @default.
- W2019929192 creator A5040454598 @default.
- W2019929192 creator A5052078738 @default.
- W2019929192 creator A5059367621 @default.
- W2019929192 creator A5076042419 @default.
- W2019929192 creator A5083477796 @default.
- W2019929192 date "1989-12-01" @default.
- W2019929192 modified "2023-10-18" @default.
- W2019929192 title "Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patients" @default.
- W2019929192 doi "https://doi.org/10.1097/00002030-198912000-00009" @default.
- W2019929192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2576628" @default.
- W2019929192 hasPublicationYear "1989" @default.
- W2019929192 type Work @default.
- W2019929192 sameAs 2019929192 @default.
- W2019929192 citedByCount "21" @default.
- W2019929192 crossrefType "journal-article" @default.
- W2019929192 hasAuthorship W2019929192A5000969643 @default.
- W2019929192 hasAuthorship W2019929192A5005540742 @default.
- W2019929192 hasAuthorship W2019929192A5010761183 @default.
- W2019929192 hasAuthorship W2019929192A5029679351 @default.
- W2019929192 hasAuthorship W2019929192A5032703463 @default.
- W2019929192 hasAuthorship W2019929192A5040454598 @default.
- W2019929192 hasAuthorship W2019929192A5052078738 @default.
- W2019929192 hasAuthorship W2019929192A5059367621 @default.
- W2019929192 hasAuthorship W2019929192A5076042419 @default.
- W2019929192 hasAuthorship W2019929192A5083477796 @default.
- W2019929192 hasConcept C112705442 @default.
- W2019929192 hasConcept C126322002 @default.
- W2019929192 hasConcept C159047783 @default.
- W2019929192 hasConcept C159654299 @default.
- W2019929192 hasConcept C202751555 @default.
- W2019929192 hasConcept C203014093 @default.
- W2019929192 hasConcept C2522874641 @default.
- W2019929192 hasConcept C2776090121 @default.
- W2019929192 hasConcept C2780216070 @default.
- W2019929192 hasConcept C2780648854 @default.
- W2019929192 hasConcept C2780727368 @default.
- W2019929192 hasConcept C542903549 @default.
- W2019929192 hasConcept C55493867 @default.
- W2019929192 hasConcept C71924100 @default.
- W2019929192 hasConcept C86803240 @default.
- W2019929192 hasConcept C8891405 @default.
- W2019929192 hasConcept C98274493 @default.
- W2019929192 hasConceptScore W2019929192C112705442 @default.
- W2019929192 hasConceptScore W2019929192C126322002 @default.
- W2019929192 hasConceptScore W2019929192C159047783 @default.
- W2019929192 hasConceptScore W2019929192C159654299 @default.
- W2019929192 hasConceptScore W2019929192C202751555 @default.
- W2019929192 hasConceptScore W2019929192C203014093 @default.
- W2019929192 hasConceptScore W2019929192C2522874641 @default.
- W2019929192 hasConceptScore W2019929192C2776090121 @default.
- W2019929192 hasConceptScore W2019929192C2780216070 @default.
- W2019929192 hasConceptScore W2019929192C2780648854 @default.
- W2019929192 hasConceptScore W2019929192C2780727368 @default.
- W2019929192 hasConceptScore W2019929192C542903549 @default.
- W2019929192 hasConceptScore W2019929192C55493867 @default.
- W2019929192 hasConceptScore W2019929192C71924100 @default.
- W2019929192 hasConceptScore W2019929192C86803240 @default.
- W2019929192 hasConceptScore W2019929192C8891405 @default.
- W2019929192 hasConceptScore W2019929192C98274493 @default.
- W2019929192 hasIssue "12" @default.
- W2019929192 hasLocation W20199291921 @default.
- W2019929192 hasLocation W20199291922 @default.
- W2019929192 hasOpenAccess W2019929192 @default.
- W2019929192 hasPrimaryLocation W20199291921 @default.
- W2019929192 hasRelatedWork W1971236148 @default.
- W2019929192 hasRelatedWork W1975455892 @default.
- W2019929192 hasRelatedWork W1986143785 @default.
- W2019929192 hasRelatedWork W1994344298 @default.
- W2019929192 hasRelatedWork W1996305828 @default.
- W2019929192 hasRelatedWork W2008001785 @default.
- W2019929192 hasRelatedWork W2050374169 @default.
- W2019929192 hasRelatedWork W2435989539 @default.
- W2019929192 hasRelatedWork W2762899668 @default.
- W2019929192 hasRelatedWork W876414892 @default.
- W2019929192 hasVolume "3" @default.
- W2019929192 isParatext "false" @default.
- W2019929192 isRetracted "false" @default.
- W2019929192 magId "2019929192" @default.
- W2019929192 workType "article" @default.